The Journal of Infectious Diseases · 2023 · 22 citations · 15 references
Veterinary MedicineImmunologyInfectious DiseasesImmunizationVaccinologyVirologyDna VaccinesNucleic Acid VaccinesVaccinationVaccine EfficacyVaccine SafetyViral VaccinesAntibodiesDeoxyribonucleic Acid (Dna) VaccineHantavirus InfectionsHantavirus VaccinesPlaque ReductionSeroconversion RatesSystemic Adverse ReactionsVaccine Clinical Trial Design
BACKGROUND: Andes virus (ANDV), a rodent-borne hantavirus, causes hantavirus pulmonary syndrome (HPS). The safety and immunogenicity of a novel ANDV DNA vaccine was evaluated. METHODS: Phase 1, double-blind, dose-escalation trial randomly assigned 48 healthy adults to placebo or ANDV DNA vaccine delivered via needle-free jet injection. Cohorts 1 and 2 received 2 mg of DNA or placebo in a 3-dose (days 1, 29, 169) or 4-dose (days 1, 29, 57, 169) schedule, respectively. Cohorts 3 and 4 received 4 mg of DNA or placebo in the 3-dose and 4-dose schedule, respectively. Subjects were monitored for safety and neutralizing antibodies by pseudovirion neutralization assay (PsVNA50) and plaque reduction neutralization test (PRNT50). RESULTS: While 98% and 65% of subjects had at least 1 local or systemic solicited adverse event (AE), respectively, most AEs were mild or moderate; no related serious AEs were detected. Cohorts 2, 3, and 4 had higher seroconversion rates than cohort 1 and seropositivity of at least 80% by day 197, sustained through day 337. PsVNA50 geometric mean titers were highest for cohort 4 on and after day 197. CONCLUSIONS: This first-in-human candidate HPS vaccine trial demonstrated that an ANDV DNA vaccine was safe and induced a robust, durable immune response. Clinical Trials Registration. NCT03682107.
15
Paula Padula, Silvia Beatriz Colavecchia, Valeria P. Martínez et al. · Journal of Clinical Microbiology · 2000 · 184 citations · Full text
Person-to-Person Household and Nosocomial Transmission of Andes Hantavirus, Southern Chile, 2011
Constanza Martínez-Valdebenito, Mario Calvo, Cecilia Vial et al. · Emerging infectious diseases · 2014 · 125 citations · Full text
Veterinary Medicine, Infectious Diseases, Infectious Disease Epidemiology +16